Q4 Earnings Forecast for McKesson Issued By Leerink Partnrs

McKesson Co. (NYSE:MCK) – Equities research analysts at Leerink Partnrs raised their Q4 2025 earnings per share (EPS) estimates for McKesson in a report issued on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $9.96 per share for the quarter, up from their previous forecast of $9.86. The consensus estimate for McKesson’s current full-year earnings is $32.72 per share. Leerink Partnrs also issued estimates for McKesson’s FY2026 earnings at $37.15 EPS and FY2028 earnings at $47.39 EPS.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a negative return on equity of 207.50% and a net margin of 0.77%.

MCK has been the topic of a number of other research reports. Wells Fargo & Company boosted their price objective on McKesson from $535.00 to $641.00 and gave the stock an “equal weight” rating in a research note on Friday, December 13th. StockNews.com upgraded McKesson from a “buy” rating to a “strong-buy” rating in a report on Thursday. Baird R W raised shares of McKesson from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 7th. Bank of America dropped their price target on shares of McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Evercore ISI raised their target price on McKesson from $650.00 to $675.00 and gave the company an “outperform” rating in a research note on Thursday. Two investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average price target of $645.79.

McKesson Trading Down 1.3 %

Shares of MCK stock opened at $598.85 on Friday. The company has a market cap of $76.02 billion, a PE ratio of 31.01, a P/E/G ratio of 1.29 and a beta of 0.52. The company’s fifty day simple moving average is $589.61 and its 200-day simple moving average is $562.56. McKesson has a 52 week low of $464.42 and a 52 week high of $637.51.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be paid a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 0.47%. The ex-dividend date of this dividend is Monday, March 3rd. McKesson’s payout ratio is 14.71%.

Insider Activity

In other McKesson news, EVP Leann B. Smith sold 579 shares of the company’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $602.81, for a total value of $349,026.99. Following the completion of the transaction, the executive vice president now owns 1,443 shares in the company, valued at approximately $869,854.83. This represents a 28.64 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.11% of the company’s stock.

Hedge Funds Weigh In On McKesson

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Czech National Bank grew its stake in shares of McKesson by 6.6% in the third quarter. Czech National Bank now owns 26,416 shares of the company’s stock worth $13,061,000 after purchasing an additional 1,645 shares in the last quarter. Brookstone Capital Management grew its position in McKesson by 15.2% in the 3rd quarter. Brookstone Capital Management now owns 7,336 shares of the company’s stock valued at $3,627,000 after buying an additional 968 shares in the last quarter. Strategic Wealth Partners Ltd. increased its stake in McKesson by 14.2% during the 3rd quarter. Strategic Wealth Partners Ltd. now owns 660 shares of the company’s stock valued at $326,000 after buying an additional 82 shares during the period. Sanibel Captiva Trust Company Inc. raised its position in shares of McKesson by 2.9% during the 3rd quarter. Sanibel Captiva Trust Company Inc. now owns 38,161 shares of the company’s stock worth $18,868,000 after buying an additional 1,083 shares in the last quarter. Finally, Steigerwald Gordon & Koch Inc. boosted its holdings in shares of McKesson by 6.5% in the third quarter. Steigerwald Gordon & Koch Inc. now owns 36,008 shares of the company’s stock valued at $17,803,000 after acquiring an additional 2,204 shares in the last quarter. 85.07% of the stock is owned by institutional investors.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.